Clinicopathologic Correlations of E-cadherin and Prrx-1 Expression Loss in Hepatocellular Carcinoma

Background Developing predictive markers for hepatocellular carcinoma (HCC) is important, because many patients experience recurrence and metastasis. Epithelial to mesenchymal transition (EMT) is a developmental process that plays an important role during embryogenesis and also during cancer metasta...

Full description

Bibliographic Details
Main Authors: Kijong Yi, Hyunsung Kim, Yumin Chung, Hyein Ahn, Jongmin Sim, Young Chan Wi, Ju Yeon Pyo, Young-Soo Song, Seung Sam Paik, Young-Ha Oh
Format: Article
Language:English
Published: Korean Society of Pathologists & the Korean Society for Cytopathology 2016-09-01
Series:Journal of Pathology and Translational Medicine
Subjects:
Online Access:http://www.jpatholtm.org/upload/pdf/jptm-2016-06-22.pdf
id doaj-0127a28f8342424e9fb6036739ec90e6
record_format Article
spelling doaj-0127a28f8342424e9fb6036739ec90e62020-11-25T01:40:08ZengKorean Society of Pathologists & the Korean Society for CytopathologyJournal of Pathology and Translational Medicine2383-78372383-78452016-09-0150532733610.4132/jptm.2016.06.2216637Clinicopathologic Correlations of E-cadherin and Prrx-1 Expression Loss in Hepatocellular CarcinomaKijong YiHyunsung KimYumin ChungHyein AhnJongmin SimYoung Chan WiJu Yeon PyoYoung-Soo SongSeung Sam PaikYoung-Ha OhBackground Developing predictive markers for hepatocellular carcinoma (HCC) is important, because many patients experience recurrence and metastasis. Epithelial to mesenchymal transition (EMT) is a developmental process that plays an important role during embryogenesis and also during cancer metastasis. Paired-related homeobox protein 1 (Prrx-1) is an EMT inducer that has recently been introduced, and its prognostic significance in HCC is largely unknown. Methods Tissue microarray was constructed using surgically resected primary HCCs from 244 cases. Immunohistochemical staining of E-cadherin and Prrx-1 was performed. The correlation between E-cadherin loss and Prrx-1 expression, as well as other clinicopathologic factors, was evaluated. Results E-cadherin expression was decreased in 96 cases (39.4%). Loss of E-cadherin correlated with a higher recurrence rate (p < .001) but was not correlated with patient’s survival. Thirty-two cases (13.3%) showed at least focal nuclear Prrx-1 immunoreactivity while all non-neoplastic livers (n = 22) were negative. Prrx-1 expression was not associated with E-cadherin loss, survival or recurrence rates, pathologic factors, or the Ki-67 labeling index. Twenty tumors that were positive for E-cadherin and Prrx-1 had significantly higher nuclear grades than the rest of the cohort (p = .037). In Cox proportional hazard models, E-cadherin loss and large vessel invasion were independent prognostic factors for shorter disease-free survival. Cirrhosis and high Ki-67 index (> 40%) were independent prognostic factors for shorter overall survival. Conclusions Prrx-1 was expressed in small portions of HCCs but not in normal livers. Additional studies with a large number of Prrx-1-positive cases are required to confirm the results of this study.http://www.jpatholtm.org/upload/pdf/jptm-2016-06-22.pdfLiverNeoplasmsEpithelial-mesenchymal transitionPrrx-1 protein
collection DOAJ
language English
format Article
sources DOAJ
author Kijong Yi
Hyunsung Kim
Yumin Chung
Hyein Ahn
Jongmin Sim
Young Chan Wi
Ju Yeon Pyo
Young-Soo Song
Seung Sam Paik
Young-Ha Oh
spellingShingle Kijong Yi
Hyunsung Kim
Yumin Chung
Hyein Ahn
Jongmin Sim
Young Chan Wi
Ju Yeon Pyo
Young-Soo Song
Seung Sam Paik
Young-Ha Oh
Clinicopathologic Correlations of E-cadherin and Prrx-1 Expression Loss in Hepatocellular Carcinoma
Journal of Pathology and Translational Medicine
Liver
Neoplasms
Epithelial-mesenchymal transition
Prrx-1 protein
author_facet Kijong Yi
Hyunsung Kim
Yumin Chung
Hyein Ahn
Jongmin Sim
Young Chan Wi
Ju Yeon Pyo
Young-Soo Song
Seung Sam Paik
Young-Ha Oh
author_sort Kijong Yi
title Clinicopathologic Correlations of E-cadherin and Prrx-1 Expression Loss in Hepatocellular Carcinoma
title_short Clinicopathologic Correlations of E-cadherin and Prrx-1 Expression Loss in Hepatocellular Carcinoma
title_full Clinicopathologic Correlations of E-cadherin and Prrx-1 Expression Loss in Hepatocellular Carcinoma
title_fullStr Clinicopathologic Correlations of E-cadherin and Prrx-1 Expression Loss in Hepatocellular Carcinoma
title_full_unstemmed Clinicopathologic Correlations of E-cadherin and Prrx-1 Expression Loss in Hepatocellular Carcinoma
title_sort clinicopathologic correlations of e-cadherin and prrx-1 expression loss in hepatocellular carcinoma
publisher Korean Society of Pathologists & the Korean Society for Cytopathology
series Journal of Pathology and Translational Medicine
issn 2383-7837
2383-7845
publishDate 2016-09-01
description Background Developing predictive markers for hepatocellular carcinoma (HCC) is important, because many patients experience recurrence and metastasis. Epithelial to mesenchymal transition (EMT) is a developmental process that plays an important role during embryogenesis and also during cancer metastasis. Paired-related homeobox protein 1 (Prrx-1) is an EMT inducer that has recently been introduced, and its prognostic significance in HCC is largely unknown. Methods Tissue microarray was constructed using surgically resected primary HCCs from 244 cases. Immunohistochemical staining of E-cadherin and Prrx-1 was performed. The correlation between E-cadherin loss and Prrx-1 expression, as well as other clinicopathologic factors, was evaluated. Results E-cadherin expression was decreased in 96 cases (39.4%). Loss of E-cadherin correlated with a higher recurrence rate (p < .001) but was not correlated with patient’s survival. Thirty-two cases (13.3%) showed at least focal nuclear Prrx-1 immunoreactivity while all non-neoplastic livers (n = 22) were negative. Prrx-1 expression was not associated with E-cadherin loss, survival or recurrence rates, pathologic factors, or the Ki-67 labeling index. Twenty tumors that were positive for E-cadherin and Prrx-1 had significantly higher nuclear grades than the rest of the cohort (p = .037). In Cox proportional hazard models, E-cadherin loss and large vessel invasion were independent prognostic factors for shorter disease-free survival. Cirrhosis and high Ki-67 index (> 40%) were independent prognostic factors for shorter overall survival. Conclusions Prrx-1 was expressed in small portions of HCCs but not in normal livers. Additional studies with a large number of Prrx-1-positive cases are required to confirm the results of this study.
topic Liver
Neoplasms
Epithelial-mesenchymal transition
Prrx-1 protein
url http://www.jpatholtm.org/upload/pdf/jptm-2016-06-22.pdf
work_keys_str_mv AT kijongyi clinicopathologiccorrelationsofecadherinandprrx1expressionlossinhepatocellularcarcinoma
AT hyunsungkim clinicopathologiccorrelationsofecadherinandprrx1expressionlossinhepatocellularcarcinoma
AT yuminchung clinicopathologiccorrelationsofecadherinandprrx1expressionlossinhepatocellularcarcinoma
AT hyeinahn clinicopathologiccorrelationsofecadherinandprrx1expressionlossinhepatocellularcarcinoma
AT jongminsim clinicopathologiccorrelationsofecadherinandprrx1expressionlossinhepatocellularcarcinoma
AT youngchanwi clinicopathologiccorrelationsofecadherinandprrx1expressionlossinhepatocellularcarcinoma
AT juyeonpyo clinicopathologiccorrelationsofecadherinandprrx1expressionlossinhepatocellularcarcinoma
AT youngsoosong clinicopathologiccorrelationsofecadherinandprrx1expressionlossinhepatocellularcarcinoma
AT seungsampaik clinicopathologiccorrelationsofecadherinandprrx1expressionlossinhepatocellularcarcinoma
AT younghaoh clinicopathologiccorrelationsofecadherinandprrx1expressionlossinhepatocellularcarcinoma
_version_ 1725046904746672128